VitaNova Life Sciences Corporation: 10-K filed 2021-07-01

Name: VitaNova Life Sciences Corporation: 10-K filed 2021-07-01
Creator: VitaNova Life Sciences Corporation

What VitaNova Life Sciences Corporation reported in its annual report filed 2021-07-01 (fiscal FY 2021): 21 published measures, 44 facts as tagged in accession 0001683168-21-002805.

This filing

Form: 10-K (annual report)
Filed: 2021-07-01
Fiscal period: fiscal FY 2021
Accession: 0001683168-21-002805 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VitaNova Life Sciences Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2021-04-30	0	USD
At 2020-04-30	0	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2021-04-30	174,670	USD
At 2020-04-30	122,576	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2021-04-30	-174,670	USD
At 2020-04-30	-122,576	USD
At 2019-04-30	-50,242	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2021-04-30	0	USD
At 2020-04-30	0	USD
At 2019-04-30	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	-52,094	USD	365
2019-05-01 to 2020-04-30	-72,334	USD	366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	-42,286	USD	365
2019-05-01 to 2020-04-30	-53,579	USD	366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	0	USD	365
2019-05-01 to 2020-04-30	0	USD	366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	42,286	USD	365
2019-05-01 to 2020-04-30	53,579	USD	366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	0	USD	365
2019-05-01 to 2020-04-30	0	USD	366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2021-04-30	-239,365	USD
At 2020-04-30	-187,271	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	0	USD	365
2019-05-01 to 2020-04-30	0	USD	366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	-52,094	USD	365
2019-05-01 to 2020-04-30	-72,334	USD	366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2021-04-30	0	USD
At 2020-04-30	0	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2021-04-30	174,670	USD
At 2020-04-30	122,576	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	52,094	USD	365
2019-05-01 to 2020-04-30	72,334	USD	366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2021-04-30	5,871,250	shares
At 2020-04-30	5,871,250	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2021-04-30	58,824	USD
At 2020-04-30	58,824	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2021-04-30	0	USD
At 2020-04-30	0	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	52,094	USD	365
2019-05-01 to 2020-04-30	72,334	USD	366

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	0	USD	365
2019-05-01 to 2020-04-30	0	USD	366

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2020-05-01 to 2021-04-30	0	USD	365
2019-05-01 to 2020-04-30	0	USD	366

Inspect the source

Entity: VitaNova Life Sciences Corporation / CIK 0001699709
Captured: 2026-09-21T17:23:55.214Z
SEC response SHA-256: cbbc169c744671a8d8af3ef9e33d6f01a860c1244f31147d1b245c430a85543c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001699709.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))